cse: ORIG

There’s a bright future in

psychedelic therapeutic treatments.

Supported by science, we see the opportunity to support innovators as they bring these new psychedelic treatments to market.

Stay Updated

By subscribing, you agree to receive emails from Origin. You may choose to unsubscribe at any time

A Global Psychedelic-Focused Investment Opportunity

Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry.

Our Approach

A robust strategy guided by HEAL principles.



The industry developing now has the potential to enhance mental health and well-being. We are investing in a diverse portfolio with one commonality: the betterment of all of us.



Knowing the market, is winning the market. Our in-house expertise and relationships with industry specialists allows us to make decisions from a position of strength.



Brokering partnerships with key players gives us access to exclusive opportunities.



The most important asset we have is our team which brings insight, analysis and executive skill backed by decades of collective experience.

Our Investment Strategy

We focus on companies with an exemplary management team and high growth potential.